FUS and amyotrophic lateral sclerosis: While we [40] and others [47–50] demonstrated that FUS aggregation is not required for disease initiation in mice expressing ALS-linked FUS mutations, but rather for its misaccumulation in axons and cytoplasm, respectively, here we devised to test whether FUS aggregation contributes to disease progression.